Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON

Authors

Danielle Antin‐Ozerkis
Vincent Cottin (ORCID: https://orcid.org/0000-0002-5591-0955)
Corinna Miede
Carl Coeck
Nazia Chaudhuri (ORCID: https://orcid.org/0000-0003-3325-6996)
Francesco Bonella (ORCID: https://orcid.org/0000-0001-7579-9767)
Mihaela Dumistracel
Jin Woo Song (ORCID: https://orcid.org/0000-0001-5121-3522)
Francesco Varone (ORCID: https://orcid.org/0000-0003-2443-8069)
Wim Wuyts (ORCID: https://orcid.org/0000-0001-9648-3497)

Institutions

Université Claude Bernard Lyon 1 (FR)
Ulsan College (KR)
Boehringer Ingelheim (Germany) (DE)
University of Ulster (GB)
Asan Medical Center (KR)
Agostino Gemelli University Polyclinic (IT)
Yale University (US)
University of Ulsan (KR)
Ruhrlandklinik (DE)
Hospices Civils de Lyon (FR)
Boehringer Ingelheim (Belgium) (BE)
Reference Institute for Bioanalytics (DE)
Hôpital Louis Pradel (FR)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)
KU Leuven (BE)

Publication Details

Journal: Lung
Published: 2025-01-09
DOI: https://doi.org/10.1007/s00408-024-00778-z
Citations: 7
Primary Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type: article
Field-Weighted Citation Impact: 10.63

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON

Danielle Antin‐Ozerkis, Vincent Cottin, Corinna Miede, Carl Coeck et al.

Jan 9, 2025

7 citations

Lung

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

10.63

article

Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON

Danielle Antin‐Ozerkis, Vincent Cottin, Corinna Miede, Carl Coeck, Nazia Chaudhuri, Francesco Bonella, Mihaela Dumistracel, Jin Woo Song, Francesco Varone, Wim Wuyts

January 9, 2025article en

7 citations

Abstract

No abstract available for this paper.

LungVol. 203(1)

Université Claude Bernard Lyon 1 (FR), Ulsan College (KR), Boehringer Ingelheim (Germany) (DE), University of Ulster (GB), Asan Medical Center (KR), Agostino Gemelli University Polyclinic (IT), Yale University (US), University of Ulsan (KR), Ruhrlandklinik (DE), Hospices Civils de Lyon (FR), Boehringer Ingelheim (Belgium) (BE), Reference Institute for Bioanalytics (DE), Hôpital Louis Pradel (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), KU Leuven (BE)

Zero hunger

Openalex Percentile: Top 2%

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

10.63

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON — Danielle Antin‐Ozerkis, Vincent Cottin, et al. · Lung (2025) | TGRS Research Map | TGRS